Title for MeetingAbstracts
Alphabetical listing of titles
Erythrocytes Serve as a Reservoir for HIV-1.
Erythrocytosis Following Chronic Androgen Use in HIV Infected Individuals.
Erythromycin in the treatment of PCP in AIDS patients.
Erythromycin Resistance Genes in Streptococcus pneumoniae from Blood and Other Sites.
Erythromycin Resistance in Streptococcus pyogenes in France: Incidence and Genetic Basis of Resistance.
Erythromycin versus Fluoroquinolones in the Treatment of Legionnaires Disease.
Erythropoietin in Tumour Anaemia - an Assessment.
Erythropoietin Is Neuroprotective in in vitro Models of HIV Neuropathy.
Erythropoietin receptors and responsiveness by splenic endothelial cells.
Erythropoietin serum-levels in HIV infected patients with anemia and with/without AZT-treatment.
ESBL Testing, Interpretation, and Reporting.
ESBLs' Detection: Comparative Analysis of Different Methods in an Area with Uncommon Resistance Markers.
Escalating dose phase I study of intravenous and oral 2',3'-dideoxyinosine (DDI) in patients with AIDS or ARC.
Escalating dose tolerance trial of recombinant soluble CD4 in humans.
Escalating multiple-dose safety and tolerance of WR 6026 in HIV-infected subjects.
Escalating single and multiple dose safety, tolerance and pharmacokinetics (PK) of delavirdine mesylate (DLV, U- 90152S) in normal volunteers.
Escalating single dose safety, tolerance and pharmacokinetics of U-87201E in healthy male volunteers.
Escape and reversion in CTL epitopes: insights into the utility of CTL responses for HIV.
Escape from neutralizing antibody responses by sequence variation in the SIV envelope.
Escape in one of two novel CTL epitopes restricted by a common macaque MHC class I molecule: implications for vaccine studies.
Escape mutants of molecularly cloned feline immunodeficiency virus used for the identification of a neutralizing determinant.
Escape of HIV-1 from cytotoxic T lymphocytes in vitro.
Escape of viremia and rapid development of protease mutations in advanced HIV infection treated with saquinavir plus ritonavir.
ESCAPE PATHWAYS FOR CCR5-SPECIFIC INHIBITORS OF HIV-1 ENTRY.
Escape recombinants of HIV-1 in a dual-infected transfusion recipient.
Escape recombinants of HIV-1 in a dually-infected transfusion recipient.
Escherichia coli Bloodstream Infections (BSI) caused by Ciprofloxacin Resistant Bacteria (CIP-R): Impact of Incorrect Empirical Therapy.
Escherichia coli Carrying stx Genes: Prevalence of stx Variants and Their Clinical Significance.
ESCUN: An effective strategy which favours the adherence to the antiretroviral therapy in people with HIV/AIDS.
Esomeprazole versus omeprazole for gastro-esophageal reflux disease: a systematic review.